Cannabivarichromene

Cannabivarichromene (CBC) is a cannabinoid found in the Cannabis plant. It is one of the 113 cannabinoids discovered in the cannabis plant, although it is less well-known than other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Chemistry[edit | edit source]

CBC is a cannabichromene type of cannabinoid. It is structurally similar to other natural cannabinoids, including THC, CBD, and cannabichromene (CBG). CBC is derived from cannabigerolic acid (CBGA), the parent molecule from which other cannabinoids are synthesized.

Pharmacology[edit | edit source]

CBC does not have the same psychoactive effects as THC. Instead, it interacts with other receptors in the endocannabinoid system, such as the vanilloid receptor 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1). Both of these receptors are linked to pain perception. When CBC activates these receptors, increased concentrations of the body's natural endocannabinoids like anandamide are released.

Potential Medical Uses[edit | edit source]

While research into the potential medical uses of CBC is still in its early stages, some studies suggest that it may have therapeutic potential. For example, a 2013 study published in the British Journal of Pharmacology found that CBC may have anti-inflammatory properties, while a 2014 study in the Journal of Neuroimmune Pharmacology suggested that CBC may promote neurogenesis, or the growth of new brain cells.

Legal Status[edit | edit source]

The legal status of CBC varies by country. In the United States, it is not listed in the Controlled Substances Act, but it is technically illegal under federal law due to its relation to THC. However, many states have legalized cannabis and its derivatives, including CBC.